Cabozantinib S-malate in Treating Patients With Relapsed Osteosarcoma or Ewing Sarcoma

Clinical trial NCT02243605 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02243605
Sponsor: National Cancer Institute (NCI)
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Ewing Sarcoma Metastatic Osteosarcoma Recurrent Ewing Sarcoma Recurrent Osteosarcoma Stage III Osteosarcoma AJCC v7 Stage IV Osteosarcoma AJCC v7 Stage IVA Osteosarcoma AJCC v7 Stage IVB Osteosarcoma AJCC v7 Unresectable Ewing Sarcoma Unresectable Osteosarcoma

Start date: 2014-12-19
Primary completion: 2019-06-30
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.